Feature|Videos|January 2, 2025
Looking Towards the Future of CAR T-cell Trials
Delivering the same safe product to a patient while improving timelines of clinical trials
Advertisement
Episodes in this series
The panelists explain how they hope CAR T-cell clinical trials will improve over time. Tactics like developing scalable manufacturing techniques, having adaptive manufacturing, streamlining regulatory approval, and gaining early feedback from regulatory bodies will help quicken clinical trial processes.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
2
Preparing for the July 31 Pharma Tariff Deadline
3
FDA Announces Seven Participants to PreCheck Pilot Program
4
Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge
5